FR2260330A1 - Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index - Google Patents

Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index

Info

Publication number
FR2260330A1
FR2260330A1 FR7404096A FR7404096A FR2260330A1 FR 2260330 A1 FR2260330 A1 FR 2260330A1 FR 7404096 A FR7404096 A FR 7404096A FR 7404096 A FR7404096 A FR 7404096A FR 2260330 A1 FR2260330 A1 FR 2260330A1
Authority
FR
France
Prior art keywords
pyridoxine
hypolipaemiant
therapeutic index
hypocholesterolemiant
nicotinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7404096A
Other languages
English (en)
French (fr)
Other versions
FR2260330B1 (en, 2012
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Priority to FR7404096A priority Critical patent/FR2260330A1/fr
Publication of FR2260330A1 publication Critical patent/FR2260330A1/fr
Application granted granted Critical
Publication of FR2260330B1 publication Critical patent/FR2260330B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/672-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FR7404096A 1974-02-07 1974-02-07 Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index Granted FR2260330A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7404096A FR2260330A1 (en) 1974-02-07 1974-02-07 Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7404096A FR2260330A1 (en) 1974-02-07 1974-02-07 Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index

Publications (2)

Publication Number Publication Date
FR2260330A1 true FR2260330A1 (en) 1975-09-05
FR2260330B1 FR2260330B1 (en, 2012) 1977-11-04

Family

ID=9134613

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7404096A Granted FR2260330A1 (en) 1974-02-07 1974-02-07 Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index

Country Status (1)

Country Link
FR (1) FR2260330A1 (en, 2012)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019324A1 (en) * 1993-02-23 1994-09-01 Laboratori Baldacci Spa Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate
WO2011147772A1 (en) 2010-05-25 2011-12-01 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists
WO2013014060A1 (en) 2011-07-26 2013-01-31 Boehringer Ingelheim International Gmbh Substituted quinolines and their use as medicaments
WO2015140054A1 (en) 2014-03-19 2015-09-24 Boehringer Ingelheim International Gmbh Heteroaryl syk inhibitors

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019324A1 (en) * 1993-02-23 1994-09-01 Laboratori Baldacci Spa Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate
WO2011147772A1 (en) 2010-05-25 2011-12-01 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists
WO2013014060A1 (en) 2011-07-26 2013-01-31 Boehringer Ingelheim International Gmbh Substituted quinolines and their use as medicaments
WO2015140054A1 (en) 2014-03-19 2015-09-24 Boehringer Ingelheim International Gmbh Heteroaryl syk inhibitors
WO2015140051A1 (en) 2014-03-19 2015-09-24 Boehringer Ingelheim International Gmbh Heteroaryl sik inhibitors
WO2015140055A1 (en) 2014-03-19 2015-09-24 Boehringer Ingelheim International Gmbh Heteroaryl syk inhibitors

Also Published As

Publication number Publication date
FR2260330B1 (en, 2012) 1977-11-04

Similar Documents

Publication Publication Date Title
AU464663B2 (en) Improvements in or relating to 1,4-dihydro pyridinedicarboxylic acid esters
DK0661973T3 (da) Fremgangsmåde til forebyggelse af NMDA-receptorkompleksmedieret neuronskade
SE8804570D0 (sv) New ciclosporin crystal form process for its produktion pharmaceutical compositions containing it and its use
PT66789A (en) Process for the preparation of pharmaceutical compositions having high rate of resorption,from heart glicosides,in se hardly resorptive,to be parenterically administered
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
FR2260330A1 (en) Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index
DE3586879D1 (de) Pyridinderivate und verfahren zu ihrer herstellung.
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
FI832252A0 (fi) Foerbaettrat foerfarande foer produktion av interferon
GB1505601A (en) Process for the production of glycidyl methacrylate
JPS5271488A (en) Improvement in producing cyanuric acid
CA1025458A (en) N-arylcarbamic acid esters, processes for their preparation and their use as plant-growth regulators
FR2113947A1 (en) Oral raubasine compositions - also contg polyethylene glycol to improve resorption
ES8100661A1 (es) Un procedimiento para la preparacion de 1-(3-bromo-isoxa- zol-5-il)-2-tercibutilaminoetanol
ATE40993T1 (de) Herstellung von n-substituierten azetidin-3carbons|urederivaten.
CA1034521A (en) PROCESS FOR THE PREPARATION OF 17-ACYL ESTERS OF 17.alpha.,21-DIHYDROXYSTEROIDS OF THE PREGNANE SERIES
JPS5419652A (en) Lead bonding method
FR2288516A2 (fr) Nouveaux bis-(carboxyalcoylene-thio)-1,10 decanes et leurs derives
FR2283675A1 (fr) Compose antifibrinolytique de synthese et son procede de fabrication
JPS5210257A (en) Preparation of benzofuran derivatives
FR2253502A1 (en) 14,15-Dihydro eburnamenine-14-thione - by treatment of 14,15-dihydro eburnamenine-14-one with a phosphorus sulphide
JPS528635A (en) Ornaments and method for connecting them continuously
JPS52140496A (en) Production of nitrous oxide
GB1377998A (en) Pharmaceutical preparations for the treatment of pubertas praecox
ES428172A1 (es) Un procedimiento para preparar acido 5-pivaloiloxi-5-(1-fe-niletil)-barbiturico.

Legal Events

Date Code Title Description
ST Notification of lapse